iCoreConnect Inc. (NASDAQ:ICCT) Short Interest Update

iCoreConnect Inc. (NASDAQ:ICCT) was the recipient of a significant increase in short interest during the month of October. As of October 15th, there was short interest totalling 146,800 shares, an increase of 321.8% from the September 30th total of 34,800 shares. Based on an average trading volume of 1,830,000 shares, the short-interest ratio is currently 0.1 days. Approximately 1.6% of the company’s stock are sold short.

iCoreConnect Stock Performance

Shares of iCoreConnect stock traded down $0.02 during trading on Friday, hitting $0.26. 250,418 shares of the company’s stock traded hands, compared to its average volume of 788,492. The company has a debt-to-equity ratio of 7.93, a current ratio of 0.11 and a quick ratio of 0.11. iCoreConnect has a 1 year low of $0.25 and a 1 year high of $3.20. The stock has a market capitalization of $2.71 million, a P/E ratio of -0.09 and a beta of 0.54. The business has a 50-day simple moving average of $0.44 and a 200-day simple moving average of $0.76.

iCoreConnect (NASDAQ:ICCT) last released its quarterly earnings data on Friday, August 16th. The company reported ($1.10) EPS for the quarter. iCoreConnect had a negative net margin of 260.79% and a negative return on equity of 614.22%. The business had revenue of $3.09 million for the quarter.

iCoreConnect Company Profile

iCoreConnect Inc, a cloud-based software and technology company, provides Health Insurance Portability and Accountability Act (HIPAA) compliant cloud-based software as a service (SaaS) in the United States. The company’s products include iCoreRx, a HIPAA compliant electronic prescription software; iCorePDMP, a solution that checks the patient’s Prescription Drug Monitoring Program (PDMP) history before prescribing controlled substances; iCoreVerify and iCoreVerify+, a HIPAA compliant SaaS solution that automatically retrieves a patients insurance eligibility breakdown to verify their benefits in advance of their appointment and on-demand; iCoreHuddle and iCoreHuddle+, a tool to instantly reveal the revenue potential of each patient; and iCoreCodeGenius, a medical coding reference SaaS solution.